Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384698265> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4384698265 abstract "Abstract Background Nocturnal eating behavior in patients with sleep‐related eating disorder (SRED) is difficult to control and can become chronic, causing weight gain and psychological distress. Here, we report a case of SRED comorbid with major depressive disorder successfully treated by switching from brotizolam to suvorexant, that is, from a benzodiazepine to an orexin receptor antagonist. Case Presentation A 25‐year‐old woman complained of night snacking with partial/complete amnesia and sleepwalking for 1 year. She had a diagnosis of major depressive disorder at age 20 and was on paroxetine and brotizolam for depression and insomnia. At 24 years of age, she experienced her second depressive episode, then her amnestic nocturnal eating became prominent. Even after improvement in depressive symptoms, she experienced uncontrollable nocturnal eating episodes every 2 days, resulting in weight gain of over 10 kg. After a partial amnestic eating episode following an awakening from stage N2 sleep was confirmed through video polysomnography, she was diagnosed with SRED. Considering her strong desire to resolve involuntary eating, we instructed her to discontinue brotizolam and start suvorexant. Subsequently, her nocturnal eating completely disappeared. She experienced rebound insomnia, which improved within 1 month. She was then continued on 10 mg of suvorexant and has not experienced nocturnal eating for 2 years. Conclusion This case highlights the importance of discontinuing benzodiazepines in the treatment of SRED, but also suggests the potential benefit of orexin receptor antagonists in the treatment of SRED. The efficacy of orexin receptor antagonists in idiopathic SRED should be tested in future studies." @default.
- W4384698265 created "2023-07-20" @default.
- W4384698265 creator A5001934558 @default.
- W4384698265 creator A5025817963 @default.
- W4384698265 creator A5030446932 @default.
- W4384698265 creator A5032662523 @default.
- W4384698265 creator A5047866067 @default.
- W4384698265 date "2023-07-17" @default.
- W4384698265 modified "2023-09-26" @default.
- W4384698265 title "Treatment of sleep‐related eating disorder with suvorexant: A case report on the potential benefits of replacing benzodiazepines with orexin receptor antagonists" @default.
- W4384698265 cites W2001044314 @default.
- W4384698265 cites W2009095423 @default.
- W4384698265 cites W2029497026 @default.
- W4384698265 cites W2050188600 @default.
- W4384698265 cites W2080072810 @default.
- W4384698265 cites W2107534273 @default.
- W4384698265 cites W2135298466 @default.
- W4384698265 cites W2248542823 @default.
- W4384698265 cites W2333155974 @default.
- W4384698265 cites W2488120613 @default.
- W4384698265 cites W2539992626 @default.
- W4384698265 cites W2598429061 @default.
- W4384698265 cites W2781196260 @default.
- W4384698265 cites W2896290603 @default.
- W4384698265 cites W3042780417 @default.
- W4384698265 cites W3133839773 @default.
- W4384698265 cites W3186202283 @default.
- W4384698265 cites W4240892394 @default.
- W4384698265 doi "https://doi.org/10.1002/pcn5.123" @default.
- W4384698265 hasPublicationYear "2023" @default.
- W4384698265 type Work @default.
- W4384698265 citedByCount "0" @default.
- W4384698265 crossrefType "journal-article" @default.
- W4384698265 hasAuthorship W4384698265A5001934558 @default.
- W4384698265 hasAuthorship W4384698265A5025817963 @default.
- W4384698265 hasAuthorship W4384698265A5030446932 @default.
- W4384698265 hasAuthorship W4384698265A5032662523 @default.
- W4384698265 hasAuthorship W4384698265A5047866067 @default.
- W4384698265 hasBestOaLocation W43846982651 @default.
- W4384698265 hasConcept C118303440 @default.
- W4384698265 hasConcept C118552586 @default.
- W4384698265 hasConcept C126322002 @default.
- W4384698265 hasConcept C15744967 @default.
- W4384698265 hasConcept C170493617 @default.
- W4384698265 hasConcept C2778205975 @default.
- W4384698265 hasConcept C2779605129 @default.
- W4384698265 hasConcept C2779680196 @default.
- W4384698265 hasConcept C2780051608 @default.
- W4384698265 hasConcept C2780733359 @default.
- W4384698265 hasConcept C2781210498 @default.
- W4384698265 hasConcept C2781326671 @default.
- W4384698265 hasConcept C71924100 @default.
- W4384698265 hasConceptScore W4384698265C118303440 @default.
- W4384698265 hasConceptScore W4384698265C118552586 @default.
- W4384698265 hasConceptScore W4384698265C126322002 @default.
- W4384698265 hasConceptScore W4384698265C15744967 @default.
- W4384698265 hasConceptScore W4384698265C170493617 @default.
- W4384698265 hasConceptScore W4384698265C2778205975 @default.
- W4384698265 hasConceptScore W4384698265C2779605129 @default.
- W4384698265 hasConceptScore W4384698265C2779680196 @default.
- W4384698265 hasConceptScore W4384698265C2780051608 @default.
- W4384698265 hasConceptScore W4384698265C2780733359 @default.
- W4384698265 hasConceptScore W4384698265C2781210498 @default.
- W4384698265 hasConceptScore W4384698265C2781326671 @default.
- W4384698265 hasConceptScore W4384698265C71924100 @default.
- W4384698265 hasFunder F4320334764 @default.
- W4384698265 hasIssue "3" @default.
- W4384698265 hasLocation W43846982651 @default.
- W4384698265 hasOpenAccess W4384698265 @default.
- W4384698265 hasPrimaryLocation W43846982651 @default.
- W4384698265 hasRelatedWork W1581771528 @default.
- W4384698265 hasRelatedWork W1966757180 @default.
- W4384698265 hasRelatedWork W2051712994 @default.
- W4384698265 hasRelatedWork W2077895426 @default.
- W4384698265 hasRelatedWork W2566041917 @default.
- W4384698265 hasRelatedWork W2993139793 @default.
- W4384698265 hasRelatedWork W3086795417 @default.
- W4384698265 hasRelatedWork W3199423763 @default.
- W4384698265 hasRelatedWork W4243008958 @default.
- W4384698265 hasRelatedWork W4292197069 @default.
- W4384698265 hasVolume "2" @default.
- W4384698265 isParatext "false" @default.
- W4384698265 isRetracted "false" @default.
- W4384698265 workType "article" @default.